Immunogen Inc 's ability to collect accounts receivable sequentially worsen to 4.54, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Immunogen Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 80 days, from 58 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 453 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 1921 to 2996.

What is Receivable Turnover Ratio?
What is Immunogen Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IMGN Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	18019.24 %	2669.57 %	491.58 %	107.38 %	-85.02 %
Y / Y Revenue Change	637.72 %	487.16 %	30.97 %	47.07 %	66.94 %
Receivable Turnover Ratio (TTM)	4.54	6.29	10.43	19.36	25.22
IMGN's Total Ranking	# 2996	# 1921	# 140	# 1596	# 1992
Accounts Receivable average collection period days	80	58	35	19	14
Seq. Receivable Change	73.49 %	169.58 %	102.39 %	1814.23 %	-73.48 %
Seq. Revenue Change	36.41 %	66.74 %	21.14 %	167.75 %	8.57 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 156
Healthcare Sector	# 454
Overall Market	# 2996

Receivable Turnover Ratio Statistics
High	Average	Low
29.07	18.44	4.54
(Mar 31 2015)		(Sep 30 2023)

IMGN Company Profile • Back to IMGN Efficiency Comparisons • Compare IMGN Receivables Turnover Ratio to its Competitors

Financial Statements
Immunogen Inc 's Accounts Receivable	$ 134 Millions	Visit IMGN's Balance sheet
Immunogen Inc 's Sales TTM	$ 288 Millions	Visit IMGN's Income Statement
Sources of IMGN's Revenues		Visit IMGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IMGN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IMGN's Growth Rates	IMGN's Roa	IMGN's Inventory Turnover Ratio	IMGN's Dividend Comparisons
IMGN's Profitability Ratios	IMGN's Roi	IMGN's Asset Turnover Ratio	IMGN's Dividend Growth
IMGN's Valuation Ratios	IMGN's Roe	IMGN's Financial Strength Ratios	IMGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Enovis Corp	5.91	$ 1,660.189 Millions	$ 281.033 Millions
Biomerica Inc	5.88	$ 5.415 Millions	$ 0.920 Millions
Novavax inc	5.88	$ 1,049.762 Millions	$ 178.443 Millions
Biogen Inc	5.87	$ 9,993.300 Millions	$ 1,701.675 Millions
Jaguar Health Inc	5.86	$ 10.721 Millions	$ 1.828 Millions
Baxter International Inc	5.86	$ 14,951.000 Millions	$ 2,553.250 Millions
Champions Oncology Inc	5.85	$ 49.978 Millions	$ 8.549 Millions
Steris Plc	5.84	$ 5,227.733 Millions	$ 894.790 Millions
Cartesian Therapeutics Inc	5.82	$ 34.533 Millions	$ 5.930 Millions
Amphastar Pharmaceuticals Inc	5.82	$ 601.313 Millions	$ 103.287 Millions
Genedx Holdings Corp	5.81	$ 205.505 Millions	$ 35.377 Millions
Rhythm Pharmaceuticals Inc	5.80	$ 61.984 Millions	$ 10.678 Millions
Maravai Lifesciences Holdings Inc	5.80	$ 419.517 Millions	$ 72.390 Millions
Sanuwave Health Inc	5.80	$ 18.902 Millions	$ 3.262 Millions
Avantor Inc	5.79	$ 7,039.400 Millions	$ 1,215.475 Millions
Rxsight Inc	5.78	$ 75.323 Millions	$ 13.041 Millions
Treace Medical Concepts Inc	5.75	$ 153.618 Millions	$ 26.697 Millions
Merck and Co Inc	5.75	$ 59,314.000 Millions	$ 10,322.250 Millions
Marker Therapeutics inc	5.74	$ 9.064 Millions	$ 1.579 Millions
Urogen Pharma Ltd	5.71	$ 76.465 Millions	$ 13.387 Millions
Cidara Therapeutics Inc	5.68	$ 56.818 Millions	$ 9.999 Millions
Fortress Biotech Inc	5.68	$ 80.971 Millions	$ 14.259 Millions
Paragon 28 inc	5.67	$ 206.942 Millions	$ 36.500 Millions
Astrotech Corp	5.66	$ 1.137 Millions	$ 0.201 Millions
Privia Health Group Inc	5.65	$ 1,581.333 Millions	$ 280.109 Millions
West Pharmaceutical Services Inc	5.64	$ 2,926.400 Millions	$ 518.575 Millions
Incyte Corporation	5.63	$ 3,609.008 Millions	$ 640.981 Millions
Bio rad Laboratories Inc	5.60	$ 2,719.298 Millions	$ 485.474 Millions
Keenova Therapeutics Plc	5.60	$ 2,266.100 Millions	$ 404.625 Millions
Zynex inc	5.57	$ 185.842 Millions	$ 33.342 Millions

Date modified: 2026-08-29T17:15:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.